Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Immunol. 2011 Aug 3;187(5):2595–2601. doi: 10.4049/jimmunol.1100088

Figure 6. MPYS-deficient BMM cells fail to activate IRF3 in response to treatment with cyclic dinucleotide monophosphates.

Figure 6

A–B Bone-marrow-derived macrophages (BMM) from indicated mice were treated with 20μM synthetic c-di-GMP (A.) or c-di-AMP (B.) for indicated times as before. WCL were separated by SDS-PAGE and probed with indicated Abs as in Fig 3. These experiments have been repeated twice.